Benzodiazepines are the mainstay of alcohol detoxification treatment, with extensive evidence supporting their efficacy and relative safety. (1) The risk of benzodiazepine-alcohol interaction, however, and psychomotor and cognitive impairments associated with benzodiazepine use may limit early rehabilitation efforts in hospitalized patients. (2) Cross-tolerance with alcohol also limits benzodiazepines' potential benefit in outpatients with substance use disorders.
[ILLUSTRATION OMITTED]
[ILLUSTRATION OMITTED]
Adding anticonvulsants to acute benzodiazepine therapy has been shown to decrease alcohol withdrawal symptom severity, reduce seizure risk, and support recovery, particularly in patients with multiple alcohol withdrawal episodes. After detoxification, long-term anticonvulsant use may reduce relapse risk by decreasing post-cessation craving, without abuse liability. (3)
Although not all studies endorse adding anticonvulsants to benzodiazepines for managing alcohol withdrawal syndrome (AWS), (4) we present 3 cases in which anticonvulsants were used successfully as adjuncts to lorazepam. Valproic acid, levetiracetam, and gabapentin offer advantages in acute and long-term therapy of alcohol dependence with efficacy in AWS, low abuse potential, benign safety profile, and mood-stabilizing properties.
[ILLUSTRATION OMITTED]
Neurobiologic rationale
AWS manifests as a cluster of clinical symptoms including delirium tremens (DTs) and seizures (Table 1, page 28). Its pathophysiology can be explained by alcohol's agonist effect on the gamma-aminobutyric acid (GABA) system and antagonist effect on the glutamatergic system (Table 2, page 35).(5)
Table 1
Alcohol withdrawal: Acute vs long-term symptoms
Alcohol withdrawal syndrome Protracted withdrawal
syndrome
Description Cluster of symptoms in Constellation of symptoms
alcohol-dependent persons lasting weeks to months
after heavy or prolonged after alcohol use ends
alcohol use has lessened or
ceased
Presentation Develops during acute Develops after 5- to
detoxification period and 7-day acute
lasts 5 to 7 days detoxification period and
may persist for 1 year
Symptoms Mild: insomnia, tremor, Sleep disruption;
anxiety, GI upset, anxiety; depressive
headache, diaphoresis, symptoms; irritability;
palpitations, anorexia increased breathing rate,
Severe: alcoholic body temperature, blood
Hallucinosis pressure, and pulse
Seizures
(generalized tonic-clonic)
occur in up to 25% of
withdrawal episodes,
usually within 24 hours
after alcohol cessation
Delirium tremens
(characterized by
hallucinations,
disorientation,
tachycardia, hypertension,
low-grade fever, agitation,
and diaphoresis) occurs in
up to 5% of patients
undergoing withdrawal, may
be delayed 4 to 5 days, and
has mortality rates
reaching 15%
GI: gastroinestinal
Source: For a bibliography, see this article at
CurrentPsychiatry.com
Table 2
How alcohol affects GABA and glutamate neurotransmitters
GABA Glutamate
GABA, the brain's primary Glutamate, the brain's major
inhibitory neurotransmitter, excitatory neurotransmitter,
renders nerve cells less sensitive renders nerve cells more
to further signaling sensitive to further signaling
Alcohol facilitates the inhibitory Alcohol seems to inhibit the
function of the [GABA.sub.A] excitatory function of the NMDA
receptor, allowing more GABA to glutamate receptor, believed to
traverse the receptor, and leading play a role in memory,
to alcohol's intoxicating effects learning, and generation of
seizures
During alcohol withdrawal, brain Long-term alcohol …